meogti10.com성욕강화 | 먹튀중개소 먹중소) | 여자가슴짱개봉3동고스톱 | 여자가슴짱수궁동고스톱 | 여자가슴짱영등포동고스톱 | 여자가슴짱영등포동1가고스톱 > 용인점

본문 바로가기


meogti10.com성욕강화 | 먹튀중개소 먹중소) | 여자가슴짱개봉3동고스톱 | 여자가슴짱수궁동고스톱 | 여자가슴짱영등포동고스톱 | 여자가슴짱영등포동1가고스톱 pharaocasino[600,400].gif

여자가슴짱<- 바로가기

PARIS LA DEFENSE--( / ) December 21, 2018 -- Regulatory News:

Reference is made to the joint press release by Thales (Euronext Paris: HO) and Gemalto (Euronext Amsterdam and Paris: GTO) dated 27 March 2018 in relation to the launch of the recommended all-cash offer by Thales for all the issued and outstanding shares of Gemalto (the “Offer”), the publication of the Offer Document, and the joint press release of Thales and Gemalto dated 10 August 2018 in relation to the further extension of the Acceptance Period. Terms not defined in this press release will have the meaning as set forth in the Offer Document.

Thales and Gemalto announce today that they have received merger control Regulatory Clearances from both the Australian Competition and Consumer Commission and the Mexican competition authority (Comision Federal de Competencia Economica), following Thales’s commitment to divest its general purpose hardware security modules (GP HSM) business globally[1] to a suitable purchaser. This clearance is effective immediately.

Together with the antitrust clearances obtained in China, Israel, New Zealand, South Africa, Turkey, and the European Union, and clearances relating to foreign investments in Australia, Canada and the USA (CFIUS), Thales and Gemalto have now obtained 11 of the required 14 Regulatory Clearances.

Thales and Gemalto continue to work constructively with the competent antitrust authorities to obtain the remaining merger control Regulatory Clearances in Russia and the United States. In addition, Thales and Gemalto are seeking Regulatory Clearance relating to foreign investments from the competent authority in Russia.

The transaction should close shortly after all of the Regulatory Clearances have been secured, which is expected to occur in the first quarter of 2019, as announced in the joint press release dated 11 October 2018.

Further announcements will be made if and when a Regulatory Clearance has been obtained or the Offer Condition with respect to Regulatory Clearances is satisfied, waived or has become incapable of being satisfied, or as otherwise required by applicable law. As announced on 10 August 2018, the Acceptance Period has been further extended by Thales in accordance with an exemption granted by the Dutch financial markets authority (AFM) and will end two weeks after the fulfilment of the Offer Condition with respect to Regulatory Clearances or the waiver thereof (but no later than the Long Stop Date).

This is a joint press release by Thales and Gemalto pursuant to Section 4, paragraph 3 of the Dutch decree on public takeover bids (Besluit openbare biedingen Wft) and section 17 paragraph 1 of the European Market Abuse Regulation (596/2014) in connection with the recommended all-cash offer by Thales for all the issued and outstanding shares in the capital of Gemalto, including all American depositary shares. This announcement does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities in Gemalto. Any offer is only made by means of the Offer Document dated 27 March 2018, which is available on the website of Thales at and on the website of Gemalto at .

About Thales

The people we all rely on to make the world go round - they rely on Thales. Our customers come to us with big ambitions: to make life better, to keep us safer.

Combining a unique diversity of expertise, talents and cultures, our architects design and deliver extraordinary high technology solutions. Solutions that make tomorrow possible, today. From the bottom of the oceans to the depth of space and cyberspace, we help our customers think smarter and act faster - mastering ever greater complexity and every decisive moment along the way.

With 65,000 employees in 56 countries, Thales reported sales of €15.8 billion in 2017.

About Gemalto

Gemalto is the global leader in digital security, with 2017 annual revenues of €3 billion and customers in over 180 countries. We bring trust to an increasingly connected world.

>From secure software to biometrics and encryption, our technologies and services enable businesses and governments to authenticate identities and protect data so they stay safe and enable services in personal devices, connected objects, the cloud and in between.

Gemalto’s solutions are at the heart of modern life, from payment to enterprise security and the internet of things. We authenticate people, transactions and objects, encrypt data and create value for software - enabling our clients to deliver secure digital services for billions of individuals and things.

Our 15,000 employees operate out of 112 offices, 43 personalization and data centers, and 30 research and software development centers located in 48 countries.

Notice to U.S. holders of Gemalto Shares

The Offer is made for the securities of Gemalto, a public limited liability company incorporated under Dutch Law, and is subject to Dutch disclosure and procedural requirements, which are different from those of the United States of America. The Offer is made in the United States of America in compliance with Section 14(e) of the U.S. Securities Exchange Act of 1934, as amended (the “U.S. Exchange Act”), and the applicable rules and regulations promulgated thereunder, including Regulation 14E (subject to any exemptions or relief therefrom, if applicable) and otherwise in accordance with the requirements of Dutch law. Accordingly, the Offer is subject to disclosure and other procedural requirements, including with respect to the Offer timetable, settlement procedures, withdrawal, waiver of conditions and timing of payments that are different from those applicable under U.S. domestic tender offer procedures and laws.

The receipt of cash pursuant to the Offer by a U.S. holder of Gemalto Shares may be a taxable transaction for U.S. federal income tax purposes and under applicable state and local, as well as foreign and other tax laws. Each holder of Gemalto shares is urged to consult his independent professional advisor immediately regarding the tax consequences of accepting the Offer.

To the extent permissible under applicable laws and regulations, including Rule 14e-5 under the U.S. Exchange Act, and in accordance with normal Dutch practice, Thales and its affiliates or its broker and its broker’s affiliates (acting as agents or on behalf of Thales or its affiliates, as applicable) may from time to time after the date of the joint press release by Thales and Gemalto dated 17 December 2017, and other than pursuant to the Offer, directly or indirectly purchase, or arrange to purchase Shares or any securities that are convertible into, exchangeable for or exercisable for such Shares. These purchases may occur either in the open market at prevailing prices or in private transactions at negotiated prices. In no event will any such purchases be made for a price per Share that is greater than the Offer Price. To the extent information about such purchases or arrangements to purchase is made public in The Netherlands, such information will be disclosed by means of a press release or other means reasonably calculated to inform U.S. shareholders of Gemalto of such information. No purchases will be made outside of the Offer in the United States of America by or on behalf of the Thales or its affiliates. In addition, the financial advisors to Thales may also engage in ordinary course trading activities in securities of Gemalto, which may include purchases or arrangements to purchase such securities. To the extent required in The Netherlands, any information about such purchases will be announced by press release in accordance with Section 5 paragraph 4 or Section 13 of the Dutch decree on public takeover bids (Besluit openbare biedingen Wft) and posted on the website of Thales at


The distribution of this press release may, in some countries, be restricted by law or regulation. Accordingly, persons who come into possession of this document should inform themselves of and observe these restrictions. To the fullest extent permitted by applicable law, Thales and Gemalto disclaim any responsibility or liability for the violation of any such restrictions by any person. Any failure to comply with these restrictions may constitute a violation of the securities laws of that jurisdiction. Neither Thales, nor Gemalto, nor any of their advisors assumes any responsibility for any violation by any of these restrictions. Any Gemalto shareholder who is in any doubt as to his position should consult an appropriate professional advisor without delay.

Forward Looking Statements

This press release may include '“forward-looking statements” and language indicating trends, such as the words “anticipate”, “expect”, “approximate”, “believe”, “could”, “should”, “will”, “intend”, “may”, “potential” and other similar expressions. These forward-looking statements are only based upon currently available information and speak only as of the date of this press release. Such forward-looking statements are based upon management’s current expectations and are subject to a significant business, economic and competitive risks, uncertainties and contingencies, many of which are unknown and many of which Thales and Gemalto are unable to predict or control. Such factors may cause Thales and/or Gemalto’s actual results, performance or plans with respect to the transaction between Thales and Gemalto to differ materially from any future results, performance or plans expressed or implied by such forward-looking statements. Neither Thales nor Gemalto, nor any of their advisors accepts any responsibility for any financial information contained in this press release relating to the business or operations or results or financial condition of the other or their respective groups. We expressly disclaim any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained herein to reflect any change in the expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

[1] In 2017, Thales’s GP HSM business generated around 90 million euros in sales.

View source version on Newswire distributes your news across every media channels through the industry’s largest press release distribution network

슈어툰 SAINTPREX, SWITZERLAND--( / ) April 07, 2017 -- Ferring Pharmaceuticals releases its 야동네이버 SAINTCorporate Social Responsibility (CSR) review, highlighting progress on social and environmental goals in 2015 and 2016 across four key pillars for focus and activity: People, g컵 빵빵넷 Business Ethics, Environment and Community.

“We have taken a number of significant steps on our CSR journey, notably by integrating CSR into our business planning, g컵 hiring a dedicated senior director to 마에다카오리 “Weour global approach, and signing on to the United Nations Global Compact (UNGC),” said Michel Pettigrew, President of the Executive Board and g컵 별킹 Chief Operating Officer, g컵 캠스 Ferring Pharmaceuticals. “I am proud of our progress to date, and look forward to embarking on the next phase.”

In line with the requirements of the UNGC, Ferring’s 2015-2016 review highlights the contribution that Ferring is making to support the United Nations Sustainable Development Goals. In particular, Ferring is focusing on the goal of reducing maternal mortality to under 70 per 100,000 globally. A notable example is the company’s partnership with the World Health 북면홀덤 In(WHO) and MSD for Mothers, which is focused on preventing post-partum haemorrhage (PPH), the leading uZmG Inof maternal mortality in low-income countries. The partnership is currently running a clinical trial on heat stable carbetocin, a treatment developed by Ferring to prevent PPH. The trial is the largest ever clinical trial undertaken in this area - with 30,000 participants across 10 countries and 23 hospitals. If the results of the study are positive, the collaborating organisations will work together to provide access to the treatment 오류1동고스톱 Inan affordable and sustainable price, in countries with a high burden of g컵 네비도효능 maternal mortality - mainly in Africa and Asia.

In its efforts to reduce its impact on the environment, Ferring has achieved a reduction in greenhouse gas emissions relative to sales of 50% and is currently evaluating its environmental 보문동6가홀덤카페 Inbeyond direct manufacturing, along the value chain. Ferring is also engaged in supporting wider scientific efforts that make a positive contribution to a more sustainable planet. In 2016, Ferring Chairman, Frederik Paulsen, together 여의도동홀덤대회 Inexperts and academic partners, launched g컵 샤아나 the Antarctic Circumnavigation Expedition (ACE) - an intensive three-month expedition around the entire southernmost continent. Its purpose is to conduct front-line research on major environmental themes - including climate change - which first 섹시 Inapparent in the Arctic and Antarctic regions.

The CSR g컵 크레오신T Review also sets out Ferring’s CSR plans for the future which, in line with its business plan and vision, has a major focus on improving maternal health. “In line with both our company philosophy of ‘People Come First’ and our company vision 성인무료 Thebe leader in reproductive g컵 쉼터 health, we are developing a global signatory CSR platform in maternal health, an area in which we believe we can make a transformational difference,” said Helen Gallagher, Senior Director, Corporate Social Responsibility and Industry Affairs. “We will launch 한아시아 Theplatform by the end of 2017.”

Other plans g컵 남성갱년기병원 laid out in g컵 나이트몰 the review include delivering on environmental g컵 트리믹스주사기 targets for 2020, further 하지마 Othera CSR champions network, enhancing 환타TV Othercompany’s sustainable purchasing strategy, and launching a ‘work smarter, live better’ programme for employees.

Read the full g컵 남성호르몬약 달나라티비 Readat

About 여성자위 About19세영화 Aboutg컵 비아샵

Headquartered in Switzerland, Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. g컵 The company identifies, develops and markets innovative products in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedics. Ferring has its own operating subsidiaries in nearly 60 countries and markets its g컵 트리믹스사용법 products in g컵 라라티비 110 countries. To learn more about Ferring or 파워티비 Headquarteredproducts please visit

View source version on 엉덩이 Viewdistributes your news across g컵 토렌트콜 every media channels through the industry’s largest press release distribution network

에널여우꼬리구매쇼핑몰,g컵,g컵,badoo,spankwire,김이브님,지지미한국,19멍,19멍,19멍,도밍고,토토로티비,스포츠중계바셀TV,스포츠중계바셀TV,남성 강화,딜도링구매쇼핑몰,오피타임,데이툰,사오토메루이,양주홀덤,wUbPPaq,오류2동고스톱,보문동7가홀덤카페,당산동1가홀덤대회,패티쉬,누드집,코코토렌트,오케이TV,콩티비,토렌트,성생활,소라의가이드,킹콩티비,엉덩이짱,여자가슴짱,여자가슴짱,HENTAI,엑스튜브,셀리의방송국,소나기티비공.,19CGV,19CGV,19CGV,로즈마리,별밤TV,스포츠중계블랙TV,스포츠중계블랙TV,남성 팬티,여자아래쪽동영상,오빠달려,Vic카지노
전화번호 : 영업시간 :
홈페이지 : 위치정보 :


등록된 댓글이 없습니다.